EcoDrugPlus

Sodium Channel Protein Type 8 Subunit Alpha-Like

Ensembl ID : ENSPREG00000015761
Gene Symbol: LOC103465359
2 Cross references
216 Possible Orthologues:

Sodium Voltage-Gated Channel Alpha Subunit 4

Ensembl ID : ENSPREG00000012575
Gene Symbol: SCN4A
2 Cross references
186 Possible Orthologues:

Sodium Voltage-Gated Channel Alpha Subunit 4

Ensembl ID : ENSPREG00000012641
Gene Symbol: SCN4A
4 Cross references
187 Possible Orthologues:

Sodium Voltage-Gated Channel Alpha Subunit 8

Ensembl ID : ENSPREG00000022435
Gene Symbol: SCN8A
4 Cross references
215 Possible Orthologues:

Sodium- And Chloride-Dependent Gaba Transporter 1-Like

Ensembl ID : ENSPREG00000008121
Gene Symbol: LOC103467587
3 Cross references
205 Possible Orthologues:

Sodium/glucose Cotransporter 1-Like

Ensembl ID : ENSPREG00000010019
Gene Symbol: LOC103473668
3 Cross references
232 Possible Orthologues:

Sodium/glucose Cotransporter 1-Like

Ensembl ID : ENSPREG00000010069
Gene Symbol: LOC103473670
3 Cross references
231 Possible Orthologues:

Sodium/glucose Cotransporter 1-Like

Ensembl ID : ENSPREG00000009698
Gene Symbol: LOC103473669
3 Cross references
231 Possible Orthologues:

Sodium/glucose Cotransporter 1-Like

Ensembl ID : ENSPREG00000010034
Gene Symbol: LOC103473671
3 Cross references
231 Possible Orthologues:

Sodium/glucose Cotransporter 2-Like

Ensembl ID : ENSPREG00000008113
Gene Symbol: LOC103474850
3 Cross references
198 Possible Orthologues:

Sodium/hydrogen Exchanger 3

Ensembl ID : ENSPREG00000009025
Gene Symbol: LOC103473023
3 Cross references
234 Possible Orthologues:

Sodium/potassium-Transporting Atpase Subunit Alpha-1

Ensembl ID : ENSPREG00000017415
Gene Symbol: LOC103473276
2 Cross references
215 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).